Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Ferrer Group Inc. Company Profile

20:43 EDT 23rd April 2014 | BioPortfolio

Ferrer Grupo offers products of a high scientific standard, according to client needs, together with health training programmes which provide up-to-date information on the constant improvements in the fields of medicine and pharmacology, and maintain direct contact with health professionals, patients and the general public.


Edifici L'illaDiagonal, 549 5a planta


Phone: 34 93 600 37 00
Fax: 34 93 490 70 78

News Articles [224 Associated News Articles listed on BioPortfolio]

Ferrer and Janus create company Spherium Biomed to reorganize pharmaceutical group’s R&D

Ferrer will invest €15 millions over the coming four years to research new drugs for unmet medical needs.

Alexza, Ferrer Launch Adasuve Agitation Drug in Romania

Alexza Pharmaceuticals Inc. and Ferrer announced that Adasuve inhalation powder, pre-dispensed (loxapine), is now available in Romania.Read more about Alexza, Ferrer Launch Adasuve Agitation Drug in R...

Ergomed partners with Ferrer to develop new insomnia drug

CRO Ergomed Clinical Research has partnered with Ferrer to support a Phase IIa study of the insomnia drug Lorediplon.

Medimetriks licenses ozenoxacin, a novel antibacterial, from Ferrer

US specialty drug firm Medimetriks Pharmaceuticals has entered into a licensing agreement with Ferrer, a privately-held Spanish pharmaceutical company, for the commercialization rights to ozenoxacin,...

Alexza Pharmaceuticals and Ferrer announce launch of Adasuve in Romania

Alexza Pharmaceuticals and Ferrer announced that Adasuve inhalation powder, pre-dispensed (loxapine) is now available in Romania.

Ferrer links with Ildong and Ergomed for lorediplon development

Privately-held Spanish drugmaker Ferrer has executed two agreements, one with South Korea’s Ildong Pharmaceuticals and the other with Ergomed Clinical Research of the UK to support further clinical...

Alexza Pharmaceuticals and Ferrer Announce the Launch of ADASUVE (inhalation powder, loxapine) in Romania

MOUNTAIN VIEW, Calif. and BARCELONA, Spain, March 13, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) and Ferrer today announced that ADASUVE® inhalation powder, pre-dispensed (lo...

Ergomed, Ferrer to Co-Develop Insomnia Drug

Ergomed Clinical Research Ltd.Read more about Ergomed, Ferrer to Co-Develop Insomnia DrugComments

PubMed Articles [2026 Associated PubMed Articles listed on BioPortfolio]

The Ontogeny of the Motivation That Underlies In-Group Bias.

Humans demonstrate a clear bias toward members of their own group over members of other groups in a variety of ways. It has been argued that the motivation underlying this in-group bias in adults may...

The Attenuation of Lung Ischemia Reperfusion Injury by Oxymatrine.

To investigate the protective effects of oxymatrine (OMT) on lung ischemia reperfusion injury (LIRI) in rabbits, models of LIRI in rabbit were used. Thirty-two rabbits were randomly divided into four...

Isoflavone intake inhibits the development of 7,12-dimethylbenz(a)anthracene(DMBA)-induced mammary tumors in normal and ovariectomized rats.

To determine the associations between isoflavone (49.72% genistin, 5.32% daidzin, 34.54% glycitin) and breast cancer risk, 150 rats were given 5 mg 7,12-dimethylbenz(a)anthracene and half of them wer...

Group Psychotherapy in Psychiatric Residency Training.

Residents (n=114) in the department of psychiatry at the University of Toronto were surveyed in the spring of 1987 about their training in and attitudes about group psychotherapy. Significant interest...

Hematological Parameters and RBC TBARS Level of Q 10 Supplemented Tribal Sickle Cell Patients: A Hospital Based Study.

The study has been undertaken as number of sickle cell patients in Chhattisgarh tribal population is 23.7 %. The Co enzyme Q10 is a strong antioxidant and energy producing compound. The patients were...

Clinical Trials [1332 Associated Clinical Trials listed on BioPortfolio]

Does Cognitive Rehabilitation Demonstrate Benefits in the Group Setting With People Whom Have Experienced Brain Injury?

The purpose of this study is to determine whether there is benefit from providing cognitive rehabilitation in the group setting. Several standardized tools will be used to measure progres...

Short Term Group Therapy for OCD

Assessing OCD before and after group therapy

Psychological Prevention of Internalizing Disorders

The purpose of this study is to determine whether cognitive-behavioral group prevention (CBT-G) for german children is effective and to what extent parental group training moderates outcom...

Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine -

The purpose of the study is to verify superiority of the lafutidine group over the placebo group and non-inferiority to the famotidine group in terms of endoscopic healing rate of the pati...

Clinical Trial of Donepezil Between the Naive Group and the Switching Group

To compare the clinical efficacy of donepezil between the naive group and the switching group.

Companies [1384 Associated Companies listed on BioPortfolio]

Ferrer Group Inc.

Ferrer Grupo offers products of a high scientific standard, according to client needs, together with health training programmes which provide up-to-date information on the constant improvements in the...

Ferrer Freeman & Company, LLC

Ferrer Freeman & Company, LLC, is a private equity firm located in Greenwich, CT focuses exclusively on growth capital investments in the healthcare industry. Since its founding i...

DiaGenic ASA & Ferrer inCode

DiaGenic is an innovative Norwegian biotechnology company that seeks to create value for patients, partners, and investors by developing new and more patient friendly methods for...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

More Information about "Ferrer Group Inc." on BioPortfolio

We have published hundreds of Ferrer Group Inc. news stories on BioPortfolio along with dozens of Ferrer Group Inc. Clinical Trials and PubMed Articles about Ferrer Group Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ferrer Group Inc. Companies in our database. You can also find out about relevant Ferrer Group Inc. Drugs and Medications on this site too.

Search BioPortfolio:

Corporate Database Quicklinks

Searches Linking to this Company Record